News
![refractory chronic gout](/sites/default/files/styles/x_large/public/2024-07/feet-gout-swollen.jpg?itok=JzE7EC7f)
Sobi starts rolling FDA filing for chronic gout drug
Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to cu